MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light and moisture. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Feldene 20mg capsules (Pfizer Ltd) and Piroxicam 20mg capsules (Accord Healthcare Ltd).

Stability Notes

Protect from light and moisture. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Feldene 20mg capsules (Pfizer Ltd) and Piroxicam 20mg capsules (Accord Healthcare Ltd).

Stability Notes

Protect from light and moisture. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Feldene 20mg capsules (Pfizer Ltd) and Piroxicam 20mg capsules (Accord Healthcare Ltd).

Stability Notes

Protect from light and moisture. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Feldene 20mg capsules (Pfizer Ltd) and Piroxicam 20mg capsules (Accord Healthcare Ltd).

Stability Notes

Protect from light and moisture. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Feldene 20mg capsules (Pfizer Ltd) and Piroxicam 20mg capsules (Accord Healthcare Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Selexid 200mg tablets (Karo Pharma).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Selexid 200mg tablets (Karo Pharma).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Selexid 200mg tablets (Karo Pharma).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Selexid 200mg tablets (Karo Pharma).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.